References
- Mire DE, Silfani TN, Pugsley MK. A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker. J Cardiovasc Pharmacol. 2005;46:585-593. https://doi.org/10.1097/01.fjc.0000180902.78230.fd
- Mizuno M, Sada T, Ikeda M, Fukuda N, Miyamoto M, Yanagisawa H, Koike H. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol. 1995;285:181-188. https://doi.org/10.1016/0014-2999(95)00401-6
- Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001;103:904-912. https://doi.org/10.1161/01.CIR.103.6.904
- Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med. 1996;334:1649-1654. https://doi.org/10.1056/NEJM199606203342507
- Kakuta H, Sudoh K, Sasamata M, Yamagishi S. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers. Int J Clin Pharmacol Res. 2005;25:41-46.
- Le MT, Pugsley MK, Vauquelin G, Van Liefde I. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor. Br J Pharmacol. 2007;151:952-962.
- Oparil S, Silfani TN, Walker JF. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. Am J Hypertens. 2005;18:287-294. https://doi.org/10.1016/j.amjhyper.2004.07.021
- Smith DHG. Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade. Am J Hypertens. 2002;15:108-114.
- Teschemacher AG, Seward EP. Bidirectional modulation of exocytosis by angiotensin II involves multiple G-protein-regulated transduction pathways in chromaffin cells. The J Neurosci. 2000;20:4776-4785.
- Uresin Y, Erbas B, Ozek M, Ozkok E, Gürol AO. Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress. J Renin Angiotensin Aldosterone Syst. 2004;5:93-96. https://doi.org/10.3317/jraas.2004.017
-
Seltzer A, Bregonzio C, Armando I, Baiardi G, Saavedra JM. Oral administration of an
$AT_{1}$ receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res. 2004;1028:9-18. https://doi.org/10.1016/j.brainres.2004.06.079 - Critchley L, Ding B, Fok B, Wang D, Tomlinson B, James A, Thomas GN, Critchley J. The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs. Eur J Pharmacol. 2004;489:67-75. https://doi.org/10.1016/j.ejphar.2004.02.036
-
Takekoshi K, Ishii K, Kawakami Y, Isobe K, Nakai T. Activation of angiotensin II subtype 2 receptor induces catecholamine release in an extracellular
$Ca^{2+}$ -dependent manner through a decrease of cyclic guanosine 3',5'-monophosphate production in cultured porcine adrenal medullary chromaffin cells. Endocrinol. 2001;142:3075-3086. https://doi.org/10.1210/en.142.7.3075 -
Martineau D, Lamouche S, Briand R, Yamaguchi N. Functional involvement of angiotensin
$AT_{2}$ receptor in adrenal catecholamine secretion in vivo. Can J Physiol Pharmacol. 1999;77: 367-374. https://doi.org/10.1139/y99-037 - Worck RH, Frandsen E, Ibsen H, Petersen JS. AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia. Hyperten. 1998;31:384-390. https://doi.org/10.1161/01.HYP.31.1.384
- Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol. 1981;313:463-480.
- Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962;138:360-375.
- Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. New York: Speringer-Verlag; 1987. 132 p.
-
Hammer R, Giachetti A. Muscarinic receptor subtypes:
$M_{1}$ and$M_{2}$ biochemical and functional characterization. Life Sci. 1982; 31:2992-2998. - Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature. 1984;309:69-71. https://doi.org/10.1038/309069a0
- Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res. 1992;15:115-125. https://doi.org/10.1007/BF02974085
-
Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on
$Ca^{2+}$ binding and$Ca^{2+}$ permeability. Biochem Pharmacol. 1989;38: 3995-4003. https://doi.org/10.1016/0006-2952(89)90679-5 -
Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the
$Ca^{2+}$ -ATPase of sarcoplasimc reticulum. J Biol Chem. 1989;264:17816-17823. - Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000;26:13-25. https://doi.org/10.1016/S0896-6273(00)81133-2
-
Wada A, Takara H, Izumi F, Kobayashi H, Yanagihara N. Influx of
$^{22}Na$ through acetylcholine receptor-associated Na channels: relationship between$^{22}Na$ influx,$^{45}Ca$ influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience. 1985;15:283-292. https://doi.org/10.1016/0306-4522(85)90135-6 - Hano T, Mizukoshi M, Baba A, Nakamura N, Nishio I. Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland. Blood Press. 1994;5:S105-108.
- Livett BG, Marley PD. Non cholinergic control of adrenal catecholamine secretion. J Anat. 1993;183:277-289.
- Plunkett LM, Correa FM, Saavedra JM. Quantitative autoradiographic determination of angiotensin-converting enzyme binding in rat pituitary and adrenal glands with 124I-351A, a specific inhibitor. Regul Pept. 1985;28:263-272.
- Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue rennin angiotensin systems. Regul Pept. 1993;43:1-20. https://doi.org/10.1016/0167-0115(93)90403-U
- Israel A, Strömberg C, Tsutsumi K, Garrido MR, Torres M, Saavedra JM. Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain Res Bull. 1995;38:441-446. https://doi.org/10.1016/0361-9230(95)02011-F
- Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther. 1990;255:584-592.
-
Armando I, Carranza A, Nishimura Y, Hoe KL, Barontini M, Terron JA, Falcon-Neri A, Ito T, Jourio AV, Saavedra JM. Peripheral administration of and angiotensin II
$AT_{1}$ receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology. 2001;142:3880-3889. https://doi.org/10.1210/en.142.9.3880 - Yang G, Xi Z, Wan Y, Wang H, Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol Signals. 1993;2:166-172. https://doi.org/10.1159/000109488
- McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol. 1995;57:521-546. https://doi.org/10.1146/annurev.ph.57.030195.002513
-
Cheek TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne RD. Spatial localization of the stimulus-induced rise in cyrosolic
$Ca^{2+}$ in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS Lett. 1989;247:429-434. https://doi.org/10.1016/0014-5793(89)81385-7 - Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science. 1995;268:239-247. https://doi.org/10.1126/science.7716515
-
Holz RW, Senter RA, Frye RA. Relationship between
$Ca^{2+}$ uptake and catecholamine secretion in primary dissociated cultures of adrenal modulla. J Neurochem. 1982;39:635-640. https://doi.org/10.1111/j.1471-4159.1982.tb07940.x -
Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum
$Ca^{2+}$ -pump, reduces$Ca^{2+}$ -dependent$K^{+}$ currents in guinea-pig smooth muscle cells. Br J Pharmacol. 1992;107:134-140. https://doi.org/10.1111/j.1476-5381.1992.tb14475.x - Challiss RA, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem. 1991;56: 1083-1086. https://doi.org/10.1111/j.1471-4159.1991.tb02033.x
- Dendorfer A, Raasch W, Tempel K, Dominiak P. Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol. 1998;93:S24-29. https://doi.org/10.1007/s003950050202
- Stoehr SJ, Smolen JE, Holz RW, Agranoff BW. Inositol trisphosphate mobilizes intracellular calcium in permeabilized adrenal chromaffin cells. J Neurochem. 1986;46:637-640. https://doi.org/10.1111/j.1471-4159.1986.tb13014.x
- Dunn LA, Holz RW. Catecholamine secretion from digitonintreated adrenal medullary chromaffin cells. J Biol Chem. 1983;258:4989-4993.
- Vijayapandi P, Nagappa AN. Biphasic effects of losartan potassium on immobility in mice. Yakugaku Zasshi. 2005;125: 653-657. https://doi.org/10.1248/yakushi.125.653
- Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ. Angiotensin regulates release and synthesis of serotonin in brain. Science. 1978;202:1091-1093. https://doi.org/10.1126/science.152460
-
Han HJ, Park SH, Koh HJ, Taub M. Mechanism of regulation of
$Na^{+}$ transport by angiotensin II in primary renal cells. Kidney Int. 2000;57:2457-2467. https://doi.org/10.1046/j.1523-1755.2000.00104.x
Cited by
- Depression-like Effect of Telmisartan in Mice Forced Swim Test: Involvement of Brain Monoaminergic System vol.7, pp.2, 2010, https://doi.org/10.3923/jpt.2012.87.95